Heidelberg Pharma AG

09/23/2024 | Press release | Distributed by Public on 09/23/2024 05:22

PR: Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024